Graftide M 500mg Tablet

Graftide M 500mg Tablet is an immunosuppressant containing mycophenolate mofetil as the active ingredient. It is an inosine monophosphate dehydrogenase (IMPDH) inhibitor used to prevent organ rejection in patients who have received an organ transplant, including kidney, heart, or liver transplantation. The medicine is prescribed as part of combination therapy with other immunosuppressive drugs.

This medicine is contraindicated in pregnancy due to the risk of birth defects and miscarriage. It should not be used in pregnant women unless no suitable alternatives exist and the potential benefits justify the risks. Women of childbearing age should use effective contraception during treatment to prevent pregnancy.

Live vaccines must not be administered while taking Graftide M 500mg Tablet due to reduced vaccine effectiveness and increased risk of infection. Patients should not donate blood during treatment and for at least six weeks after discontinuing the medication to ensure adequate clearance from the body.

Do not take this medicine if you are allergic to mycophenolate mofetil or any other components. Inform your doctor of existing liver or heart disease before starting treatment. As this drug suppresses immune defenses, it increases the risk of skin cancer. Patients should take precautions to limit exposure to sunlight and ultraviolet (UV) light.

Seek immediate medical attention if you develop bruising under the skin, fever, unexplained tiredness, dizziness, yellowing of the skin or eyes, vision impairment, reduced urine output, or seizures after taking this medicine.

Graftide M 500mg Tablet is an immunosuppressive medication that may affect the infant's developing immune system and should be avoided during breastfeeding. In some cases, alternative medications with a more favourable safety profile during breastfeeding may be considered.

Prevent organ transplant rejections

Graftide M 500mg Tablet works by inhibiting the enzyme inosine monophosphate dehydrogenase (IMPDH) and reducing the production of guanosine nucleotides. MMF specifically affects the proliferation of activated T and B lymphocytes. These lymphocytes are key players in the immune response that can lead to the rejection of a transplanted organ

It is an orally available prescription drug. Your physician will decide the dose and duration of the treatment based on your disease condition, severity, and other factors. Always take Graftide M 500mg Tablet as prescribed by your doctor. Do not open, crush, break, or chew the medicine.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious Infections, fever, or sore throat Unusual bleeding or bruising Low blood cell count Severe allergic reactions Common Higher risk of developing lymphoma and other cancers Nausea, abdominal pain Diarrhea Constipation Loss of appetite Shortness of breath Weight loss Increased heartbeat Headache Blood pressure problem Anaemia

It is necessary to take the prescribed dose exactly as instructed by your doctor. Inform your doctor about all the medications (prescription, over-the-counter, and herbal) you are taking, as they can interact with this drug. If you plan to conceive or suspect you might be pregnant while taking Graftide M 500mg Tablet, it is important to consult your doctor immediately. They may suggest switching to alternative medications that are safer during pregnancy or adjusting your treatment plan.